Abstract
ObjectivesRituximab (RTX) is a biological treatment used off-label in patients with systemic lupus erythematosus (SLE). This survey aimed to investigate the off-label use of RTX in Europe and compare the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have